Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany.
about
Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspectiveCost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgiaBurden of herpes zoster and postherpetic neuralgia in Japanese adults 60 years of age or older: Results from an observational, prospective, physician practice-based cohort study.Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: findings from the Zoster Quality of Life (ZQOL) studySystematic review of incidence and complications of herpes zoster: towards a global perspective.Treatment of peripheral neuropathic pain by topical capsaicin: Impact of pre-existing pain in the QUEPP-studyHealth economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany.The humanistic, economic and societal burden of herpes zoster in Europe: a critical reviewEvaluation of the economic burden of Herpes Zoster (HZ) infection.Burden of herpes zoster and post-herpetic neuralgia in Sweden.Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in GermanyIncreasing incidence associated with herpes zoster infection in British Columbia, CanadaCurrent and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccinationPersistent dilemmas in zoster eye disease.Assessment of the potential public health impact of Herpes Zoster vaccination in Germany.Diagnosis, antiviral therapy, and prophylaxis of varicella-zoster virus infections.Price of pain: population-based cohort burden of disease analysis of medication cost of herpes zoster and postherpetic neuralgia.The changing landscape of antiviral treatment of herpes zoster: a 17-year population-based cohort study.Dyshidrosis is a risk factor for herpes zoster.[Frequent pathogen-induced diseases of the scalp].Varicella-zoster virus-derived major histocompatibility complex class I-restricted peptide affinity is a determining factor in the HLA risk profile for the development of postherpetic neuralgia.Economic Burden of Herpes Zoster and Post-Herpetic Neuralgia in Adults 60 Years of Age or Older: Results from a Prospective, Physician Practice-Based Cohort Study in Kushiro, Japan.Acute herpes zoster and post herpetic neuralgia in primary care: a study of diagnosis, treatment and cost.Background paper to the decision not to recommend a standard vaccination with the live attenuated herpes zoster vaccine for the elderly in Germany : Statement of the German Standing Committee on Vaccination (STIKO) at the Robert Koch Institute (RKI)Prevention of post-herpetic neuralgia using transcutaneous electrical nerve stimulation.Epidemiology and long-term disease burden of herpes zoster and postherpetic neuralgia in Taiwan: a population-based, propensity score-matched cohort study.Comparison of the efficacy and safety of pregabalin for postherpetic neuralgia in Chinese and international patients
P2860
Q26781940-CA11454F-5280-4FF6-8B19-B1FCDDAA87B0Q28468596-20DC3FE1-51C7-43CC-8900-E856B1B44A38Q33626007-E7E5068B-8E2D-4FDB-804A-06B4AD48A596Q33776676-FD87BF9B-013B-4874-B165-C78D6F6A8334Q33795551-1766BA5B-954C-447F-9997-3C3114164D28Q34548800-74FDE812-29A0-4D47-ACC5-29E808FDB646Q35000186-12CFAD52-FE79-41DA-80D6-3F8455C8CF49Q35147612-EEC7B9C6-2D72-4D20-8DA0-8176733A4856Q35498396-7C0CD1B2-FFE8-4E2C-87B6-CDE657AC5F76Q35639805-B570EE00-6E53-4A00-B087-736B8072ED91Q35887517-0701396A-DB25-4CA2-B18C-A4737E98E54FQ36169787-53AC2E76-A419-4C05-88E9-3E63D72BF4B8Q37135445-B92695A5-04AB-47CA-8757-E064F331D9E4Q38475791-CC2A5B84-06AA-401D-804A-9FCDADE3F6BFQ38678770-E09904D0-866D-4972-BF23-0120B4DAE4D8Q38731791-5694F6A0-5FE2-4BF5-94EC-195AF4F93213Q39479153-4A03AD75-3DB7-4E5B-BFE5-23CBFF3EA84EQ39694343-437BF542-B5A8-4BCB-A528-56B1B4EFE608Q41007667-AF253B02-465B-485B-BD81-BF91D09AD291Q41662953-3214AB4C-8634-4EDE-89E1-1EAC321E671FQ41684668-8C2ADCDB-68ED-4A5E-9BAF-DA8DAFCE0251Q47116379-B567FCAB-FEA8-4FBB-BE40-CA827150439DQ47346906-E3593E6B-DC1F-4B41-98C1-5F91F4BCD148Q50210244-C817D7A2-EAF4-436E-B9BC-39C174791946Q51000087-ED27120E-0896-4DC2-B82D-ED0ABA54E943Q51761737-D07BB592-4F10-4481-99E7-54269C04C961Q58767868-2951AEE0-35BF-4100-8876-BC00C93C0277
P2860
Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany.
@en
Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany.
@nl
type
label
Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany.
@en
Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany.
@nl
prefLabel
Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany.
@en
Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany.
@nl
P2093
P2860
P1476
Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany.
@en
P2093
Andrea Icks
Anette Siedler
Bernhard Ultsch
Ingrid Köster
Ingrid Schubert
Thomas Reinhold
P2860
P2888
P304
P356
10.1007/S10198-012-0452-1
P577
2012-12-28T00:00:00Z